MedTrace Logo

Efficacy and Speed of Action of a Product to Control Gastric Hydration and Gastroesophageal Reflux

NCT05060744 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-05-26

No results posted yet for this study

Summary

A Randomised, Placebo-Controlled Clinical Trial off the Efficacy and Rapidity of Action of a Product Containing Sodium Alginate, Calcium and Magnesium Salts, Hyaluronic Acid and Aloe Vera to Control Oesophageal-Gastric pH and Reduce Symptoms of Gastric Reflux and Hyperacidity.

Conditions

  • Oesophageal Reflux
  • Gastric Reflux
  • Hyperactivity; Stomach

Interventions

DEVICE

Antacid

The tablets should be kept in the mouth without chewing or swallowing, allowing them to dissolve completely.

OTHER

Control

The tablets should be kept in the mouth without chewing or swallowing, allowing them to dissolve completely.

Sponsors & Collaborators

  • Uriach Consumer Healthcare

    lead INDUSTRY

Principal Investigators

  • Oriol Armengol, Ph · Primary Health Center Poblenou, Barcelona, Spain

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-09
Primary Completion
2023-05-30
Completion
2023-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05060744 on ClinicalTrials.gov